Subsequently, Tokuda et al. demonstrated using a new system for enzyme-linked immunosorbent assay (ELISA) that PD patients showed significantly lower α-synuclein levels in CSF than the control groups [31]. This evidence concerns the gene SNCA and Parkinson disease.